| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
Dezember 2010 - 61 Präparate |
|
| | FI | PI | | Solaraze 3% | 25 g | 30.40 | 51.30 | 10% | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Solaraze 3% | 50 g | 53.50 | 77.80 | 10% | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Co-Latanoprost Pfizer | 2.5 ml | 15.09 | 33.70 | 10% | | Augentropfen: 2 Wirkstoffe | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Latanoprost Pfizer | 3 x 2.5 ml | 44.36 | 67.35 | 10% | | Augentropfen: 2 Wirkstoffe | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 200mg / 20ml | Durchstechflasche(n) | 19.59 | 38.90 | 10% | | Infusionslösung: Gemcitabinum 200mg / 20ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 500mg / 50ml | Durchstechflasche(n) | 65.00 | 91.00 | 10% | | Infusionslösung: Gemcitabinum 500mg / 50ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 1000mg / 100ml | Durchstechflasche(n) | 90.25 | 120.00 | 10% | | Infusionslösung: Gemcitabinum 1000mg / 100ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 10 mg | 30 Tablette(n) | 15.40 | 34.10 | 10% | | Filmtabletten: Atorvastatinum 10 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 10 mg | 100 Tablette(n) | 50.67 | 74.55 | 10% | | Filmtabletten: Atorvastatinum 10 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 20 mg | 30 Tablette(n) | 15.36 | 34.05 | 10% | | Filmtabletten: Atorvastatinum 20 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 20 mg | 100 Tablette(n) | 50.54 | 74.40 | 10% | | Filmtabletten: Atorvastatinum 20 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 40 mg | 30 Tablette(n) | 15.36 | 34.05 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 40 mg | 100 Tablette(n) | 50.54 | 74.40 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 80 mg | 30 Tablette(n) | 15.40 | 34.10 | 10% | | Filmtabletten: Atorvastatinum 80 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Atorvastatin Pfizer 80 mg | 100 Tablette(n) | 50.67 | 74.55 | 10% | | Filmtabletten: Atorvastatinum 80 mg | Pfizer PFE Switzerland GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 80/12.5 | 28 Tablette(n) | 10.16 | 19.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 80/12.5 | 98 Tablette(n) | 32.84 | 54.10 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/12.5 | 28 Tablette(n) | 12.06 | 26.15 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/12.5 | 98 Tablette(n) | 42.16 | 64.80 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/25 | 28 Tablette(n) | 12.06 | 26.15 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/25 | 98 Tablette(n) | 42.16 | 64.80 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | | | Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g | Ampulle(n) | 19.49 | 38.75 | 10% | | poudre pour solution pour injection ou pour perfusion: 2 Wirkstoffe | Labatec Pharma SA | A / SL / SG | FB | | G |  |
L | | FI | PI | | Saizen Liquid 6 mg (5.83 mg/ml) | Zylinderampulle(n) | 219.04 | 267.85 | 10% | | Injektionslösung: Somatropinum Adnr 6mg / 1.03ml | Merck (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | PI | | Saizen Liquid 12 mg (8 mg/ml) | Zylinderampulle(n) | 438.09 | 519.35 | 10% | | Injektionslösung: Somatropinum Adnr 12mg / 1.5ml | Merck (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | PI | | Saizen Liquid 20 mg (8 mg/ml) | Zylinderampulle(n) | 730.15 | 854.60 | 10% | | Injektionslösung: Somatropinum Adnr 20mg / 2.5ml | Merck (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Cayston | 88 Durchstechflasche(n) | 2767.05 | 3082.25 | 10% | | Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler (mit Altera-Vernebler): Aztreonamum 75 mg | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
| | FI | | PS | Xeplion 25 mg | Spritze(n) | 174.37 | 216.60 | 10% | | Retardsuspension zur intramuskulären Injektion: Paliperidonum 25 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | | PS | Xeplion 50 mg | Spritze(n) | 285.97 | 344.70 | 10% | | Retardsuspension zur intramuskulären Injektion: Paliperidonum 50 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | | PS | Xeplion 75 mg | Spritze(n) | 396.81 | 471.95 | 10% | | Retardsuspension zur intramuskulären Injektion: Paliperidonum 75 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | | PS | Xeplion 100 mg | Spritze(n) | 486.02 | 574.35 | 10% | | Retardsuspension zur intramuskulären Injektion: Paliperidonum 100 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | | PS | Xeplion 150 mg | Spritze(n) | 606.80 | 713.00 | 10% | | Retardsuspension zur intramuskulären Injektion: Paliperidonum 150 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | PI | | Clarelux | 50 g | 7.10 | 16.35 | 10% | | Schaum zur Anwendung auf der Haut: Clobetasoli-17 Propionas | Pierre Fabre Pharma AG | B / SL | FB | | G |  |
| | FI | PI | | Clarelux | 100 g | 14.15 | 28.55 | 10% | | Schaum zur Anwendung auf der Haut: Clobetasoli-17 Propionas | Pierre Fabre Pharma AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Qutenza | Pflaster | 277.22 | 334.65 | 10% | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A / SL | FB | | G |  |
| | FI | | | Nutriflex Omega plus, Infusionsemulsion 1875 ml | 5 1 Sachet(s) à 1875 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Nutriflex Omega special, Infusionsemulsion 1250 ml | 5 1 Sachet(s) à 1250 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Nutriflex Omega special, Infusionsemulsion 1875 ml | 5 1 Sachet(s) à 1875 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | PI | | Codicalm | 200 ml | PA | PA | k.A. | | Sirup: Codeini Phosphas Hemihydricus 15mg / 15ml | Dr. Heinz Welti AG, Fabrikation chemisch- pharmazeutischer Produkte | C | FB | | G |  |
| | FI | PI | | Padma Digestin | 20 | PA | PA | k.A. | | Kapseln: 5 Wirkstoffe | PADMA AG | D | FB | | G |  |
| | FI | PI | | Padma Digestin | 60 | PA | PA | k.A. | | Kapseln: 5 Wirkstoffe | PADMA AG | D | FB | | G |  |
| | | PI | H | Neurexan | 30 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 4 Wirkstoffe | ebi-pharm ag | D | FB | | G |  |
| | FI | PI | | Arbid N | 30 ml | PA | PA | k.A. | | gouttes à avaler: Chlorphenamini Maleas 2 mg/g | VERFORA SA | D | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 750 mg | 750 mg | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable: Cefuroximum 750 mg | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 1,5 g | 10 x 1.5 g | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable ou pour perfusion: Cefuroximum 1.5 g | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Piperacilline-Tazobactam Labatec i.v. 2 g - 0,25 g | Ampulle(n) | 9.75 | 19.40 | 10% | | poudre pour solution pour injection ou pour perfusion: 2 Wirkstoffe | Labatec Pharma SA | A / SL / SG | FB | | G |  |
L | | FI | PI | BM | Diaphin SR 200 | 100 Tablette(n) | 309.00 | PA | 10% | | | DiaMo Narcotics GmbH | A / SL | FB | | G |  |
L | | FI | PI | BM | Diaphin IR 200 | 100 Tablette(n) | 309.00 | PA | 10% | | | DiaMo Narcotics GmbH | A / SL | FB | | G |  |
| | FI | PI | | Olanzapin Zentiva 2.5 mg | 28 | PA | PA | k.A. | | | Helvepharm AG | B | FB | | G |  |
| | FI | PI | | Olanzapin Zentiva 5 mg | 28 | PA | PA | k.A. | | | Helvepharm AG | B | FB | | G |  |
| | FI | PI | | Olanzapin Zentiva 10 mg | 28 | PA | PA | k.A. | | | Helvepharm AG | B | FB | | G |  |
| | FI | PI | | Olanzapin Zentiva 15 mg | 28 | PA | PA | k.A. | | | Helvepharm AG | B | FB | | G |  |
| | FI | | | Nutriflex Omega plus, Infusionsemulsion 1250 ml | 5 1 Sachet(s) à 1250 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Nutriflex Omega plus, Infusionsemulsion 2500 ml | 5 1 Sachet(s) à 2500 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Nutriflex Omega special, Infusionsemulsion 625 ml | 5 1 Sachet(s) à 625 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Nutriflex Omega special, Infusionsemulsion 2500 ml | 5 1 Sachet(s) à 2500 ml | PA | PA | k.A. | | Infusionsemulsion: 22 Wirkstoffe 3 Wirkstoffe 3 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | PI | | Solaraze 3% | 100 g | PA | PA | k.A. | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B | FB | | G |  |
| | FI | PI | | Qutenza | 2 Pflaster | PA | PA | k.A. | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 750 mg | 10 x 750 mg | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable: Cefuroximum 750 mg | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 1,5 g | 1.5 g | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable ou pour perfusion: Cefuroximum 1.5 g | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 1,5 g | 1.5 g | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable ou pour perfusion: Cefuroximum 1.5 g | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Cefuroxim Labatec i.v. 1,5 g | 10 x 1.5 g | PA | PA | k.A. | | poudre pour la préparation d'une solution injectable ou pour perfusion: Cefuroximum 1.5 g | Labatec Pharma SA | A | FB | | G |  |